Stock listing
Xbrane Biopharma Ab
Selected listing: A41PJJ · LS · EUR · DE
Xbrane Biopharma Ab (Lang & Schwarz: A41PJJ), Health Technology. Latest release Jul 17, 2026: Xbrane Biopharma : releases Interim Report for January-June 2026.
- Ticker
- Lang & Schwarz: A41PJJ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Lang & Schwarz
- Currency
- EUR
Latest news from Xbrane Biopharma Ab
Xbrane Biopharma : releases Interim Report for January-June 2026
July 17, 2026
Xbrane Biopharma AB and JOINN Biologics US Inc. Enter Strategic Partnership to Develop Xdarzane – Xbrane´s Biosimilar Candidate to Darzalex® (Daratumumab)
June 11, 2026
Xbrane Biopharma AB (publ) (“Xbrane” or “the Company”) (Nasdaq Stockholm: XBRANE) receives FDA BsUFA date of October 29, 2026 for its investigational biosimilar candidate to LUCENTIS® (ranibizumab)
June 3, 2026
Xbrane and its partner Intas agree on revised financing arrangement for Xbrane’s Xdivane development activities
May 5, 2026
XBRANE SUBMITS RANIBIZUMAB BIOSIMILAR CANDIDATE TO FDA
April 30, 2026
Events
Research Xbrane Biopharma Ab
Alternate listings
XBRANE:OMXSTO
SE · SEK
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
7XB0:GETTEX
DE · EUR
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
A41PJJ:LSX
DE · EUR
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
XBRANS:AQUISEU
GB · SEK
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
XBRANS:AQUISUK
GB · SEK
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
7XB0:FWB
DE · EUR
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
7XB0:MUN
DE · EUR
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.
7XB0:SWB
DE · EUR
Alternate listing for Xbrane Biopharma Ab; the primary context on this page is A41PJJ:LS.